AstraZeneca COVID-19 Vaccine would undergo stringent clinical trial in the Philippines, according to Galvez.
COVID-19 Vaccine Czar Secretary Carlito Galvez Jr. on Saturday said that AstraZeneca would undergo stringent clinical trial for its COVID-19 vaccine in the Philippines.
This, as he allayed fears on potential local use of AstraZeneca COVID-19 vaccine amidst questions on its efficacy.
Galvez, who was also the chief implementer of the National Task Force Against COVID-19, said that science was a revolving process and issues about the COVID-19 vaccine could still be corrected.
According to him, they won’t use a vaccine that had not rolled out in its country or origin.
The Philippines had sought AstraZeneca’s responses on questions about the efficacy of its COVID-19 vaccine as the private sector prepared to sign a deal to purchase doses of its COVID-19 vaccine.
Galvez explained in an interview on TeleRadyo that the money which would be used to purchase COVID-19 vaccines would come from the Asian Development Bank and the World Bank.
“Mayroon po silang napaka-stringent regulatory requirements, meaning pasado sa WHO, pangalawa dapat may 2 o 3 regulatory clearance either from US, from UK at saka from other countries,” he said.
READ ALSO: Government To Buy AstraZeneca COVID-19 Vaccine Too, Says DOST Official
Senior officials on Friday said that the Philippines had secured 2.6 million doses of AstraZeneca COVID-19 vaccine during the signing of the tripartite agreement between AstraZeneca, the Philippine government, and the private sector on Friday, which Galvez called the said initiative as “a significant development”
Officials also said that the Philippines would procure some COVID-19 vaccines and not just one brand.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph through its official Facebook page and YouTube channel as well.
